We are live on ! Find out more
MRSN

Mersana Therapeutics

Delisted

MRSN was delisted on the 5th of January, 2026.

50 hedge funds and large institutions have $283M invested in Mersana Therapeutics in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

160% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 5

89% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 9

19% more funds holding

Funds holding: 4250 (+8)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.05% less ownership

Funds ownership: 3.08%3.03% (-0.05%)

6% less capital invested

Capital invested by funds: $302M → $283M (-$19M)

Holders
50
Holders Change
+8
Holders Change %
+19.05%
% of All Funds
1.13%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
13
Increased
17
Reduced
9
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
LCM
51
Laurion Capital Management
New York
-$865K -2,000 Closed
Tudor Investment Corp
52
Tudor Investment Corp
Connecticut
-$346K -800 Closed
NFA
53
Nationwide Fund Advisors
Ohio
-$39K -89 Closed
TRCT
54
Tower Research Capital (TRC)
New York
-$5K -12 Closed
MAM
55
Meeder Asset Management
Ohio
+$436 +1 New